These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 6379455)

  • 1. Antifibrinolytic treatment in subarachnoid hemorrhage.
    Vermeulen M; Lindsay KW; Murray GD; Cheah F; Hijdra A; Muizelaar JP; Schannong M; Teasdale GM; van Crevel H; van Gijn J
    N Engl J Med; 1984 Aug; 311(7):432-7. PubMed ID: 6379455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of tranexamic acid on rebleeding after subarachnoid hemorrhage: a double-blind controlled clinical trial.
    van Rossum J; Wintzen AR; Endtz LJ; Schoen JH; de Jonge H
    Ann Neurol; 1977 Sep; 2(3):238-42. PubMed ID: 365072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term tranexamic acid treatment in aneurysmal subarachnoid hemorrhage.
    Wijdicks EF; Hasan D; Lindsay KW; Brouwers PJ; Hatfield R; Murray GD; van Gijn J; Vermeulen M
    Stroke; 1989 Dec; 20(12):1674-9. PubMed ID: 2595729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm with tranexamic acid: a double-blind clinical trial.
    Chandra B
    Ann Neurol; 1978 Jun; 3(6):502-4. PubMed ID: 354483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tranexamic acid in the preoperative management of ruptured intracranial aneurysms.
    Fodstad H; Liliequist B; Schannong M; Thulin CA
    Surg Neurol; 1978 Jul; 10(1):9-15. PubMed ID: 356311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antifibrinolysis with tranexamic acid in aneurysmal subarachnoid hemorrhage: a consecutive controlled clinical trial.
    Fodstad H; Forssell A; Liliequist B; Schannong M
    Neurosurgery; 1981 Feb; 8(2):158-65. PubMed ID: 7010203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cimetidine and tranexamic acid in the treatment of acute upper-gastrointestinal-tract bleeding.
    Barer D; Ogilvie A; Henry D; Dronfield M; Coggon D; French S; Ellis S; Atkinson M; Langman M
    N Engl J Med; 1983 Jun; 308(26):1571-5. PubMed ID: 6343868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antifibrinolytic therapy in subarachnoid hemorrhage caused by ruptured intracranial aneurysm.
    Ramirez-Lassepas M
    Neurology; 1981 Mar; 31(3):316-22. PubMed ID: 7010208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of antifibrinolytic drugs in aneurysmal subarachnoid hemorrhage.
    Schisano G
    Surg Neurol; 1978 Oct; 10(4):217-22. PubMed ID: 725719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benefits and risks of antifibrinolytic therapy in the management of ruptured intracranial aneurysms. A double-blind placebo-controlled study.
    Tsementzis SA; Hitchcock ER; Meyer CH
    Acta Neurochir (Wien); 1990; 102(1-2):1-10. PubMed ID: 2407050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double-blind trial of aspirin in patient receiving tranexamic acid for subarachnoid hemorrhage.
    Mendelow AD; Stockdill G; Steers AJ; Hayes J; Gillingham FJ
    Acta Neurochir (Wien); 1982; 62(3-4):195-202. PubMed ID: 7102384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tranexamic acid in subarachnoid hemorrhage. A double-blind study.
    Kaste M; Ramsay M
    Stroke; 1979; 10(5):519-22. PubMed ID: 505491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immediate administration of tranexamic acid and reduced incidence of early rebleeding after aneurysmal subarachnoid hemorrhage: a prospective randomized study.
    Hillman J; Fridriksson S; Nilsson O; Yu Z; Saveland H; Jakobsson KE
    J Neurosurg; 2002 Oct; 97(4):771-8. PubMed ID: 12405362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonged antifibrinolysis: an effective non-surgical treatment for ruptured intracranial aneurysms?
    Maurice-Williams RS
    Br Med J; 1978 Apr; 1(6118):945-7. PubMed ID: 346153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antifibrinolytic treatment in subarachnoid hemorrhage: a randomized placebo-controlled trial. STAR Study Group.
    Roos Y
    Neurology; 2000 Jan; 54(1):77-82. PubMed ID: 10636129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antifibrinolytic therapy in patients with aneurysmal subarachnoid hemorrhage. A report of the cooperative aneurysm study.
    Adams HP; Nibbelink DW; Torner JC; Sahs AL
    Arch Neurol; 1981 Jan; 38(1):25-9. PubMed ID: 7458720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of recurrence of spontaneous subarachnoid haemorrhage by tranexamic acid.
    Gelmers HJ
    Acta Neurochir (Wien); 1980; 52(1-2):45-50. PubMed ID: 7376944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative management of patients with aneurysmal subarachnoid hemorrhage.
    Tovi D
    J Neurosurg Sci; 1975; 19(1-2):59-64. PubMed ID: 1221096
    [No Abstract]   [Full Text] [Related]  

  • 19. Outcome of aneurysmal subarachnoid hemorrhage in patients 66 years of age and older.
    Muizelaar JP; Vermeulen M; van Crevel H; Hijdra A; van Gijn J; Teasdale GM; Lindsay KW; Murray GD
    Clin Neurol Neurosurg; 1988; 90(3):203-7. PubMed ID: 3197345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antifibrinolytic therapy in subarachnoid hemorrhage.
    Jordan KG
    N Engl J Med; 1985 Jan; 312(1):52-3. PubMed ID: 3880594
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.